SeedBlink introduces new tools to enhance equity management for European businesses and investors
BUCHAREST, Romania, Oct. 26, 2023 (GLOBE NEWSWIRE) -- SeedBlink, Europe's tech-focused venture investment and equity management platform, introduces a series of product enhancements as part of Fall Release. These updates are designed to simplify and enhance the equity understanding and access processes for European companies and their stakeholders. The new tools are for founders but also for investors.
"SeedBlink is determined to transform Europe's approach to equity ownership, bridging the gap between financial and intelligent capital. Unlike the thriving equity culture in the United States, Europe faces unique challenges. Our ongoing innovations are dedicated to revolutionizing equity access, management, and trading,” stated Andrei Dudoiu, Co-founder and Managing Partner of SeedBlink.
NimityLink, SeedBlink's flagship Ambassadors program, is redefining traditional cap tables by seamlessly integrating numerous European stakeholders into a united community. This brand-new referral initiative is positioned to be a pilot for building an esteemed European network, grounded in traceable connections from paper to empowered communities.
As NimityLink ambassadors, participants will receive SeedBlink shares, actively contribute to the product's evolution as an extended team, enjoy complimentary membership in the SeedBlink Club, gain entry to the Tech Investors Academy, and secure an exclusive invitation within a community of distinguished experts.
The program is open until the end of November and invites founders, investors, and experts who can advise European startups to be part of it and bring the power of networks together.
The tools introduced by SeedBlink for empowering founders are:
Simulations – is Nimity’s new tool designed to offer entrepreneurs an easy way to preview the financial and equity implications of prospective funding rounds from dilution to outstanding options impact. Simulations translate complex financial dynamics into understandable, dynamic visuals, enhancing transparency in equity distribution and ownership structures.
Community Stars - was launched in September and serves as a cornerstone for early-stage startups graduating from technology and business accelerators. The initiative aims to seamlessly connect innovative founders with their communities, providing crucial support during pivotal early growth phases.
Introducing EquiBot - In its beta phase, EquiBot is Nimity’s AI-powered chatbot crafted to explain complex equity management concepts for founders and investors alike. Acting as an informational aide, EquiBot aims to educate users on equity-related intricacies, offering insights into the workings of SeedBlink and Nimity.
Enhancements for Investors
SeedBlink continues to modernize the access and trading of private equity for individuals, and has refined the payments process, ensuring an intuitive, and secure experience. Moreover, SeedBlink investors can now track their complete portfolio on Nimity, even with externally held equity or startup securities.
About SeedBlink
SeedBlink's mission is to simplify and grow equity ownership in Europe. Through its range of products, financial services, and extensive network, it offers an equity management and tech-focused venture investment platform that enables European startups and their stakeholders to access, manage, and trade equity.
SeedBlink SA is registered in the Register of the Romanian Financial Supervisory Authority (ASF), under number PJR28FSFPR/400001 as of November 3, 2022, with an EU passport as per the European Securities and Market Authority (ESMA) register of crowdfunding service providers. Contact us at email: hello@seedblink.com.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/291cf0a4-f959-4051-ab40-596ce10b8031
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Changes in the number of own shares held by Aktia Bank Plc28.11.2023 13:00:00 CET | Press release
Aktia Bank Plc Stock Exchange Release 28 November 2023 at 2.00 p.m. Changes in the number of own shares held by Aktia Bank Plc Aktia Bank Plc has today, based on a decision made by the company's Board of Directors, divested a total of 808 own shares held by the company to four persons as a deferred payment based on the company’s remuneration programs. The divestment of own shares is based on the authorisation by the Annual General Meeting of Shareholders held on 5 April 2023. After the above-mentioned divestments, a total of 159,538 shares remain in the company’s possession. Aktia Bank Plc Further information: Mia Smeds, Communications director, +358 44 546 0379, mia.smeds(at)aktia.fi Distribution: Nasdaq Helsinki Ltd Mass media www.aktia.com Aktia is a Finnish asset manager, bank and life insurer that has been creating wealth and wellbeing from one generation to the next for 200 years. We serve our customers in digital channels everywhere and face-to-face in our offices in the Helsink
Ändringar i antalet egna aktier i Aktia Bank Abp:s besittning28.11.2023 13:00:00 CET | Pressemelding
Aktia Bank Abp Börsmeddelande 28.11.2023 kl. 14.00 Ändringar i antalet egna aktier i Aktia Bank Abp:s besittning Aktia Bank Abp har idag med stöd av ett beslut av bolagets styrelse överlåtit totalt 808 Aktia-aktier i bolagets besittning till fyra personer som betalning av uppskjutna ersättningar enligt bolagets belöningssystem. Överlåtelsen av aktier är baserad på bemyndiganden av den ordinarie bolagsstämman 5.4.2023. Efter ovan nämnda överlåtelser har bolaget sammanlagt 159 538 aktier i sin besittning. Aktia Bank Abp Mera information: Mia Smeds, kommunikationsdirektör, tfn 044 546 0379, mia.smeds(at)aktia.fi Distribution: Nasdaq Helsinki Oy Massmedier www.aktia.com Aktia är en finländsk kapitalförvaltare, bank och livförsäkrare som har skapat välstånd och välfärd generation efter generation redan under 200 års tid. Vi tillhandahåller våra kunder digitala tjänster i ett flertal kanaler och ger personlig service på våra verksamhetsställen i huvudstadsregionen samt i Åbo-, Tammerfors-, V
Karolinska Developments portföljbolag Umecrine Cognition presenterar positiv effekt med golexanolon i en preklinisk modell av kolestas28.11.2023 12:44:51 CET | Pressemelding
STOCKHOLM, SVERIGE 28 november 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar att portföljbolaget Umecrine Cognition har presenterat positiva resultat från en studie med bolagets läkemedelskandidat golexanolone i en preklinisk modell av PBC-relaterad symtomologi och neuroinflammation. Resultaten indikerar en normaliserande effekt på kognitiva symtom såsom trötthet, motoriska störningar, neuroinflammation och neurala signaler. Resultaten publiceras i novemberutgåvan av den internationellt välrenommerade tidskriften Liver International. Resultaten från den prekliniska studien, som utfördes i en validerad och välkänd sjukdomsmodell av kolestas, visar att golexanolon förbättrar symtom som vanligtvis ses vid PBC. Studien visar en tydlig minskning av central trötthet, signifikanta förbättringar av korttidsminnet och normaliserande motoriska funktioner efter en 4-5 veckors lång behandling med golexanolon. ”Trötthet är högst prioriterat för symtomlindring för PBC-patienter e
Karolinska Development’s portfolio company Umecrine Cognition presents positive effects of golexanolone in a preclinical model of cholestasis28.11.2023 12:44:51 CET | Press release
STOCKHOLM, SWEDEN – November 28, 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has presented positive results from a study of the company’s drug candidate golexanolone in a preclinical model of PBC-like symptomology and neuroinflammation. The results indicate a normalizing effect on cognitive symptoms, such as fatigue, motor impairments, neuroinflammation, and neural signaling. The results are published in the November issue of the internationally renowned journal Liver International. The results from the preclinical study, which was performed in a validated and well-known disease model of cholestasis, show that golexanolone improves symptoms generally seen in PBC. The study shows a clear reduction in central fatigue, marked improvements in short-term memory, and normalized motoric functions following a 4–5-week treatment regimen with golexanolone. “Fatigue is the highest priority of symptom relief for PBC patient
Vardagen fångad i blixtbelysning28.11.2023 12:19:36 CET | Pressemelding
Uppsala, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Lars Tunbjörk 2 dec - 28 jan 2024 Bror Hjorths Hus, Uppsala Lars Tunbjörks fotografier visas i Bror Hjorths Hus Årets sista utställning i Bror Hjorths Hus visar verk ut tre serier av den svenska fotografen Lars Tunbjörk (1956–2015). Den invigs lördag 2 december och pågår till 28 januari 2024. Pressvisning: lämpligast torsdag 30 november kl 10-14 (se mer nedan) Lars Tunbjörk skapade en helt egen fotografisk stil. Den genomsyrade alla hans bilder, oavsett om det rörde sig om foton av hemstaden Borås, det svenska landskapet och dess olika årstider, kontorsmiljöer eller modeller i Paris. Med en säregen blick, tålamod och passion dokumenterade han vardagen i skarp blixtbelysning. Lars Tunbjörks började som pressfotograf och 1982 fick han utmärkelsen Årets fotograf. Det stora genombrottet kom drygt tio år senare med fotoboken Landet utom sig – en både roande och oroande dokumentation av svensk vardag runt decennieskiftet 1990. Ett urval av dessa fot